Mir-29a curbs hepatocellular carcinoma incidence via targeting of hif-1 and angpt2

HIGHLIGHTS

• who: Ying-Hsien Huang et al. from the Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital Chang, Kaohsiung, TaiwanCollege of Medicine, Chang Gung University, Taoyuan, Taiwan have published the paper: MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of HIF-1 and ANGPT2, in the Journal: (JOURNAL)
• what: The authors predicted HIF-1α and as regulators of HCC by the OncoMir cancer database and showed strong positive correlation with HIF-1α and gene expression in HCC patients. The authors demonstrate that miR-29a regulates the expression of HIF-1α and ANGPT2 in_vivo and in_vitro, offering . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.